A novel series of tacrine derivatives were designed and synthesized by combining caffeic acid (CA), ferulic acid (FA) and lipoic acid (LA) with tacrine. The antioxidant study revealed that all the hybrids have much more antioxidant capacities compared to CA. Among these compounds, 1b possessed a good ability to inhibit the b-amyloid protein (Ab) self-aggregation, sub-micromole acetylcholinesterase (AChE)/butyrylcholinesterase (BuChE) inhibitory, modest BACE1 inhibitory. Moreover, compound 1b also was a DPPH radical scavenger and copper chelatory as well as had potent neuroprotective effects against glutamateinduced cell death with low toxicity in HT22 cells. Our findings suggest that the compound 1b might be a promising lead multi-targeted ligand and worthy of further developing for the therapy of Alzheimer’s disease.
Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD
DIGIACOMO, MARIA;LAPUCCI, ANNALINA;MACCHIA, MARCO;RAPPOSELLI, SIMONA
2015-01-01
Abstract
A novel series of tacrine derivatives were designed and synthesized by combining caffeic acid (CA), ferulic acid (FA) and lipoic acid (LA) with tacrine. The antioxidant study revealed that all the hybrids have much more antioxidant capacities compared to CA. Among these compounds, 1b possessed a good ability to inhibit the b-amyloid protein (Ab) self-aggregation, sub-micromole acetylcholinesterase (AChE)/butyrylcholinesterase (BuChE) inhibitory, modest BACE1 inhibitory. Moreover, compound 1b also was a DPPH radical scavenger and copper chelatory as well as had potent neuroprotective effects against glutamateinduced cell death with low toxicity in HT22 cells. Our findings suggest that the compound 1b might be a promising lead multi-targeted ligand and worthy of further developing for the therapy of Alzheimer’s disease.File | Dimensione | Formato | |
---|---|---|---|
2015 Digiacomo 25, 807-810.pdf
solo utenti autorizzati
Tipologia:
Versione finale editoriale
Licenza:
Importato da Ugov Ricerca - Accesso privato/ristretto
Dimensione
669.82 kB
Formato
Adobe PDF
|
669.82 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
BMCL-D-14-01958R1.pdf
accesso aperto
Descrizione: Revised manuscript
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
1.67 MB
Formato
Adobe PDF
|
1.67 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.